FENNEC PHARMACEUTICALS INC.（FENC）内部人交易：高管与董事近期交易
过去 18 个月，共有 13 位内部人为 FENNEC PHARMACEUTICALS INC.（FENC）报告了 159 笔 Form 4 交易（最近一笔 2026-10-01）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-01 | Andrade Robert | CHIEF FINANCIAL OFFICER | 买入 | 1,703 | $0 |
| 2026-10-01 | Hackman Jeffrey S. | Chief Executive Officer | 买入 | 1,159 | $0 |
| 2026-10-01 | Evans Terry L | Chief Commercial Officer | 买入 | 168 | $0 |
| 2026-10-01 | Sayad Pierre Sargis | Chief Medical Officer | 买入 | 168 | $0 |
| 2026-10-01 | Cioffi Christiana Marie | Chief Strategy Officer | 买入 | 156 | $0 |
| 2026-09-16 | Brughera Marco Maria | 董事 | 买入 | 15,545 | $32,800 |
| 2026-09-16 | Brughera Marco Maria | 董事 | 卖出 | 15,545 | $159,958 |
| 2026-09-01 | Raykov Rosty | 内部人 | 买入 | 2,778 | $0 |
| 2026-09-01 | Raykov Rosty | 内部人 | 卖出 | 10,000 | $121,100 |
| 2026-08-31 | Andrade Robert | CHIEF FINANCIAL OFFICER | 买入 | 1,703 | $0 |
| 2026-08-31 | Hackman Jeffrey S. | Chief Executive Officer | 买入 | 1,159 | $0 |
| 2026-08-31 | Evans Terry L | Chief Commercial Officer | 买入 | 168 | $0 |
| 2026-08-31 | Cioffi Christiana Marie | Chief Strategy Officer | 买入 | 156 | $0 |
| 2026-08-31 | Sayad Pierre Sargis | Chief Medical Officer | 卖出 | 12,000 | $146,160 |
| 2026-08-31 | Sayad Pierre Sargis | Chief Medical Officer | 买入 | 168 | $0 |
| 2026-08-28 | Andrade Robert | CHIEF FINANCIAL OFFICER | 卖出 | 75,000 | $883,500 |
| 2026-08-28 | Andrade Robert | CHIEF FINANCIAL OFFICER | 买入 | 21,928 | $111,833 |
| 2026-08-04 | Raykov Rosty | 内部人 | 卖出 | 10,000 | $95,800 |
| 2026-08-03 | Andrade Robert | CHIEF FINANCIAL OFFICER | 买入 | 1,703 | $0 |
| 2026-08-03 | Raykov Rosty | 内部人 | 买入 | 2,778 | $0 |
| 2026-08-03 | Hackman Jeffrey S. | Chief Executive Officer | 买入 | 1,159 | $0 |
| 2026-08-03 | Evans Terry L | Chief Commercial Officer | 买入 | 168 | $0 |
| 2026-08-03 | Sayad Pierre Sargis | Chief Medical Officer | 买入 | 168 | $0 |
| 2026-08-03 | Cioffi Christiana Marie | Chief Strategy Officer | 买入 | 156 | $0 |
| 2026-07-02 | Raykov Rosty | 内部人 | 买入 | 2,778 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-01